Bausch + Lomb Files Registration Statement for Proposed Initial Public Offering

Bausch Health Companies announced that in connection with its previously announced intention to separate its eye health business, its wholly owned subsidiary, Bausch + Lomb, has publicly filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) and a preliminary base post-receipt pricing procedure (PREP) prospectus with the securities regulatory authorities in each of the provinces and territories of Canada (other than Quebec) relating to a proposed initial public offering (IPO) of Bausch + Lomb's common shares concurrently in the United States and Canada. All of the shares being offered will be sold by a wholly owned subsidiary of Bausch Health. The number of common shares to be offered and the price range for the IPO have not yet been determined.

The IPO will be made only by means of a prospectus.